heart disease
Fabric Genomics, Intermountain Children's Health Partner for WGS-Based Diagnosis of Sick Kids
The collaboration aims to enhance the precision diagnosis of infants and children using the whole-genome sequencing service provided by Broad Clinical Labs.
Beckman Coulter, Roche, Proscia, T2 Biosystems Gain FDA 510(k) Clearances in February
The FDA in February granted marketing clearances for tests used for the diagnosis of a heart attack or progressive muscle diseases, androgen disorders, and bacteremia, among others.
Cardio Diagnostics Enters Private Financing Agreement for up to $11.2M
The firm intends to use the proceeds to accelerate the adoption of its PrecisionCHD and Epi+Gen CHD tests and to launch additional tests.
Numares Health Gets €40M Financing from European Investment Bank, Existing Investors
Numares will use €20 million from the EIB for research and development and the complementary €20 million from other investors to commercialize its technology.
The firm uses epigenetic and genetic information, along with machine learning to determine a patient's risk of cardiovascular disease.